Basel, 23rd September 2024 – ANSEA, a global healthcare consulting firm that enables pharmaceuticals, biopharmaceuticals and medical device companies navigate through complex healthcare systems across the world and CURELEADS, a fast-growing MENA BioPharma company with a team of experienced professionals, partnerships with top biomedical firms, and a strong presence in the region, entered into a strategic partnership wherein CURELEADS will be promoting the healthcare consulting services of ANSEA across the MENA region, through its strong footprint across multiple countries in the region.
“CURELEADS strong network and deep understanding of healthcare system dynamics across multiple countries in the Middle East and North Africa region, will allow ANSEA to offer its range of services in this fast evolving part of the world, where governments and stakeholder are committed to significantly increase their investment in healthcare for their populations”, said Anand Jha, Founder and Managing Director of ANSEA. “We look forward to a great collaboration with CURELEADS team to help bring innovative therapies and solutions to the patients in the region.”
Mohamad Rammal, Co-Founder and CEO of CURELEADS added “As health care systems in MENA are evolving more into outcome-based and value-based assessment, our strategic partnership with ANSEA, combining their expertise in market access with our deep knowledge of the health systems in MENA will help patients to get faster access to innovative medications and technologies. This partnership will help bring global best practices and innovative access approaches that are very much needed at this time in the MENA region.”
With this announcement, we are pleased to welcome Mohamad Rammal to join our Advisory Board. This collaboration with CURELEADS strengthens and expands the reach of ANSEA in newer countries where the company will be able to support patient access through stakeholder partnerships.
CONTACT
ANSEA: info@anseaconsulting.com
Cureleads: info@cureleads.com
